EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Diffusion MRI and α‐Synuclein Seed Amplification Status in Parkinson's Disease

Shannon Y Chiu iD, Wei-En Wang, Robin Chen, Jesse C DeSimone, Derek B Archer, Charles H Adler, Shyamal H Mehta, Sara R Dresler iD, Melissa J Armstrong, Nikolaus McFarland, Michael Okun, David E Vaillancourt und 1 weitere

Annals of Neurology · 2026-08 · 100 (2) · 295-304

DOI: 10.1002/ana.78252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 07.05.2026. Verfasst von Shannon Y Chiu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, AZ. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Diffusion Magnetic Resonance Imaging, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NLM NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Positive α‐synuclein seed amplification assay (SAA) is a biomarker found in most people with Parkinson's disease (PD). We explored if free‐water (FW) imaging detects microstructural differences in the brains of patients with early PD with SAA+ or SAA– status.

Methods

We studied patients with PD with baseline diffusion imaging and α‐synuclein SAA data from the Parkinson's Progression Markers Initiative (PPMI). We compared FW, FW corrected fractional anisotropy (FA T ), and clinical characteristics between SAA+ and SAA– groups. We also applied the Automated Imaging Differentiation for Parkinsonism (AIDP) at baseline to classify PD versus atypical parkinsonism, stratified by SAA status.

Results

Among 462 participants (41 SAA– and 421 SAA+), individuals with SAA+ had hyposmia and shorter motor symptom duration before baseline magnetic resonance imaging (MRI). AIDP identified PD in 92.4% (n = 427, 91.6% had SAA+) and classified 7.6% as atypical parkinsonism (n = 35, 85.7% had SAA+). At baseline, SAA+ individuals had lower FW in the superior cerebellar peduncle, compared to SAA– (pFDR < 0.05). No significant differences in FA T were found between groups.

Interpretation

Positive α‐synuclein SAA was associated with focal microstructural differences but did not distinguish broader diffusion MRI (dMRI) changes across FW and FA T metrics. These findings indicate that molecular confirmation of synuclein aggregation (via SAA) provides limited stratification of neurodegeneration detected by FW imaging in early PD. ANN NEUROL 2026;100:295–304

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseDiffusion Magnetic Resonance ImagingBrainHumansFemaleAgedMaleMiddle Aged

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, AZ.
  • Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL.
  • Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.
  • Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN.
  • Norman Fixel Institute for Neurological Diseases, Department of Neurology, University of Florida, Gainesville, FL.

ORCID-Profile: Shannon Y Chiu, Sara R Dresler

Förderung

  • NINDS NIH HHS
  • NLM NIH HHS
  • NIA NIH HHS

Zitieren

APA

Chiu, S. Y., Wang, W. E., Chen, R., DeSimone, J. C., Archer, D. B., Adler, C. H., Mehta, S. H., Dresler, S. R., Armstrong, M. J., McFarland, N., Okun, M., Vaillancourt, D. E., & Parkinson's Progression Markers Initiative (2026). Diffusion MRI and α‐Synuclein Seed Amplification Status in Parkinson's Disease. Annals of Neurology, 100(2), 295-304. https://doi.org/10.1002/ana.78252

Vancouver

Chiu SY, Wang WE, Chen R, DeSimone JC, Archer DB, Adler CH, et al. Diffusion MRI and α‐Synuclein Seed Amplification Status in Parkinson's Disease. Annals of Neurology. 2026;100(2):295-304. doi:10.1002/ana.78252

BibTeX
@article{Chiu2026,
  author = {Chiu, Shannon Y and Wang, Wei-En and Chen, Robin and DeSimone, Jesse C and Archer, Derek B and Adler, Charles H and Mehta, Shyamal H and Dresler, Sara R and Armstrong, Melissa J and McFarland, Nikolaus and Okun, Michael and Vaillancourt, David E and Parkinson's Progression Markers Initiative, Parkinson's Progression Markers Initiative},
  title = {Diffusion MRI and α‐Synuclein Seed Amplification Status in Parkinson's Disease},
  journal = {Annals of Neurology},
  year = {2026},
  volume = {100},
  number = {2},
  pages = {295--304},
  doi = {10.1002/ana.78252}
}
Kostenlos starten →